Zdrowie i gospodarka · 26/06/2025

FDA Classifies Herpes Simplex Virus Nucleic Acid-Based Assay for Central Nervous System Infections

The FDA has classified the herpes simplex virus nucleic acid-based assay for central nervous system infections into Class II, special controls, aiming to ensure safety and effectiveness while reducing regulatory burdens and enhancing patient access to innovative devices.